Genedit Is A Biotechnology Company Based In South San Franciscocaliforniafounded In 2016The Company Focuses On Enhancing Genetic Medicine Delivery Through Its Innovative Nanogalaxy Platformgenedit Develops Non Viralnon Lipid Polymer Nanoparticles That Are Designed To Safely And Efficiently Deliver Genetic Payloadssuch As Crispr Cas9 Ribonucleoproteinsto Targeted Tissues The Nanogalaxy Platform Features A Library Of Thousands Of Polymer Nanoparticleswhich Are Screened To Identify Candidates Optimized For Specific Therapeutic Applicationsthis Technology Aims To Address Delivery Challenges In Treating Diseases With High Unmet Medical Needsparticularly Genetic Disordersgenedit Is Advancing An Internal Pipeline Of Therapies And Is Positioned For Potential Collaborations In Gene Editing And Deliverytargeting Biopharmaceutical Partners And Clinical Researchersthe Leadership Team Includes Experts In Genetic Engineeringbiomaterialsand Drug Delivery
